Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats

被引:40
作者
Fujiwara, M
Ohgami, Y
Inada, K
Iwasaki, K
机构
关键词
8-arm radial maze task; spatial memory; scopolamine; arginine(8)-vasopressin (AVP(1-9)) C-terminal fragment; acetylcholine (ACh) release;
D O I
10.1016/S0166-4328(97)86051-2
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The effect of arginine(8)-vasopressin (AVP(1-9)) and its metabolite C-terminal fragments on the scopolamine-induced disruption of spatial cognition were investigated using an 8-arm radial maze task in rats. AVP(1-9), (10 mu g/kg s.c.) markedly improved the disruption of spatial cognition by treatment with scopolamine (0.5 mg/kg i.p.), and 60% of the rats recovered to a normal level. The main metabolite of AVP(1-9), AVP(4-9) (0.5 and 1 ng/kg s.c.) also significantly improved the scopolamine-induced deficit of spatial memory. The activity of AVP(4-9) was determined to be about 10000 fold greater than that of AVP(1-9). An intracerebroventricular (i.c.v.) injection of 10 fg of AVP(5-8), however, showed a lower activity. Both AVP(6-8), and AVP(5-7), which are both metabolites of AVP(5-8), demonstrated no activity. The scopolamine-induced disruption of spatial memory was found to improve after a microinjection of AVP(4-9) (1 fg) into the ventral hippocampus (VH) region, but not into the dorsal hippocampus (DH). In an in vivo microdialysis study, the scopolamine-induced acetylcholine (ACh) release from the VH was slightly potentiated by treatment with AVP(4-9) (10 fg i.c.v.). In addition, an AVP(4-9) analogue, No. 302, which is a synthetic hexapeptide and has a longer half-life, also demonstrated a markedly improved effect, which had a 10-fold higher activity than that with AVP(4-9). AVP(4-9) is the most potent activity of all the endogenous metabolites of the AVP(1-9) and the new synthetic AVP(4-9) analogue, No. 302 (obtained from Nippon Chemiphar Co.), substituting Ser for Cys-Cys in hexapeptide, has higher activity than that of AVP(4-9). These results indicated [Ser(6)] hexapeptide has an important role in behavioral activity. Based on these results, it is possible that AVP(1-9) and its metabolite AVP(4-9) could, thus, be useful in treating cholinergic dysfunction diseases, such as Alzheimer's disease. Hexapeptide may play an important role in improving the spatial memory by promoting the release of ACh in the VH region.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 29 条
[1]   HIPPOCAMPAL-LESIONS BLOCK BEHAVIORAL-EFFECTS OF CENTRAL BUT NOT OF PERIPHERAL PRETEST INJECTION OF ARGININE VASOPRESSIN IN AN APPETITIVE LEARNING-TASK [J].
ALESCIOLAUTIER, B ;
DEVIGNE, C ;
SOUMIREUMOURAT, B .
BEHAVIOURAL BRAIN RESEARCH, 1987, 26 (2-3) :159-169
[2]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[3]   EFFECTS OF VASOPRESSIN ON ACTIVE AND PASSIVE AVOIDANCE BEHAVIOR [J].
BOHUS, B ;
ADER, R ;
WIED, DD .
HORMONES AND BEHAVIOR, 1972, 3 (03) :191-&
[4]  
BRINTON RE, 1989, J NEUROSCI, V9, P752
[5]  
BUIJS RM, 1979, CELL TISSUE RES, V204, P355
[6]   INTRAHYPOTHALAMIC AND EXTRAHYPOTHALAMIC VASOPRESSIN AND OXYTOCIN PATHWAYS IN RAT [J].
BUIJS, RM ;
SWAAB, DF ;
DOGTEROM, J ;
VANLEEUWEN, FW .
CELL AND TISSUE RESEARCH, 1978, 186 (03) :423-433
[7]  
BUIJS RM, 1983, NEUROHYPOPHYSIS STRU, P115
[8]  
BURBACH JPH, 1983, J BIOL CHEM, V258, P1487
[9]   A MAJOR METABOLITE OF ARGININE VASOPRESSIN IN THE BRAIN IS A HIGHLY POTENT NEUROPEPTIDE [J].
BURBACH, JPH ;
KOVACS, GL ;
DEWIED, D ;
VANNISPEN, JW ;
GREVEN, HM .
SCIENCE, 1983, 221 (4617) :1310-1312
[10]   VASOPRESSIN CELLS IN THE MEDIAL AMYGDALA OF THE RAT PROJECT TO THE LATERAL SEPTUM AND VENTRAL HIPPOCAMPUS [J].
CAFFE, AR ;
VANLEEUWEN, FW ;
LUITEN, PGM .
JOURNAL OF COMPARATIVE NEUROLOGY, 1987, 261 (02) :237-252